About Bifarma Adiluhung
The First GMP Stem Cell and Metabolite Processing Manufacture in Indonesia. PT. Bifarma Adiluhung as one of the strategic business units was developed in 1995, is a leading biotechnology company aiming at providing clinically proven and quality guaranteed biopharmaceutical generics as well as developing innovative biopharmaceutical that requires scientific and clinical development in the global market. Bifarma Adiluhung also as a holding company who is serving the entire Kalbe Biopharma entities (7 subsidiaries and a research center) and the new business incubator in the Biopharma division. Biopharma will play important roles in future health and will be a part of the world from what we have now.
Scope of Business
Research and Development Centre for innovative cell therapy products
Education centre for stem cell
Stem cell processing for autologous purposes
GMP manufacturing of allogenic stem cell & its derivatives
Manufacturing facilities located in Pulo Gadung, Jakarta Timur, We are clinical stage biopharmaceutical manufacturing facility, the first in Indonesia with cGMP compliant from Indonesian FDA (BPOM) to manufacture stem cells and their metabolites product. Our manufacturing facility consists of three Grade B cleanrooms which are supported by Grade C and D areas. The facilities is designed with validated HEPA system and Air Handling Units (AHU). All processes are conducted under strict quality management system to ensure cell quality product meet quality standard. All personel are undergoing periodic assessment to ensure they are certified and qualified according to GMP standard
Vision
To Be The Best Asian BioSciences Company which is driven by innovation and excellent management
Mission
To improve health for a better life